| Immunogenicity of high dose influenza vaccine for patients with inflammatory bowel disease on anti-TNF monotherapy: a randomized clinical trial F Caldera, L Hillman, S Saha, A Wald, I Grimes, Y Zhang, AR Sharpe, ... Inflammatory bowel diseases 26 (4), 593-602, 2020 | 87 | 2020 |
| Humoral immunogenicity of mRNA COVID-19 vaccines among patients with inflammatory bowel disease and healthy controls F Caldera, KL Knutson, S Saha, A Wald, HS Phan, K Chun, I Grimes, ... Official journal of the American College of Gastroenterology| ACG 117 (1 …, 2022 | 48 | 2022 |
| Methotrexate reduces DNA integrity in sperm from men with inflammatory bowel disease D Ley, J Jones, J Parrish, S Salih, F Caldera, E Tirado, B Leader, S Saha Gastroenterology 154 (8), 2064-2067. e3, 2018 | 42 | 2018 |
| Optimizing immunization strategies in patients with IBD F Caldera, D Ley, MS Hayney, FA Farraye Inflammatory Bowel Diseases 27 (1), 123-133, 2021 | 40 | 2021 |
| Accuracy of self-reported vaccination status in a cohort of patients with inflammatory bowel disease R Smith, J Hubers, FA Farraye, E Sampene, MS Hayney, F Caldera Digestive diseases and sciences 66, 2935-2941, 2021 | 34 | 2021 |
| Humoral immunogenicity of 3 COVID-19 messenger RNA vaccine doses in patients with inflammatory bowel disease TL Schell, KL Knutson, S Saha, A Wald, HS Phan, M Almasry, K Chun, ... Inflammatory bowel diseases 28 (11), 1781-1786, 2022 | 31 | 2022 |
| Clear liquid diet before bowel preparation predicts successful chromoendoscopy in patients with inflammatory bowel disease B Megna, J Weiss, D Ley, S Saha, P Pfau, I Grimes, Z Li, F Caldera Gastrointestinal endoscopy 89 (2), 373-379. e2, 2019 | 26 | 2019 |
| Influenza vaccination in immunocompromised populations: Strategies to improve immunogenicity F Caldera, M Mercer, SI Samson, JM Pitt, MS Hayney Vaccine 39, A15-A23, 2021 | 25 | 2021 |
| Immunosuppression does not affect antibody concentrations to measles, mumps, and rubella in patients with inflammatory bowel disease F Caldera, EA Misch, S Saha, A Wald, Y Zhang, J Hubers, B Megna, ... Digestive Diseases and Sciences 64, 189-195, 2019 | 24 | 2019 |
| The development and initial findings of a study of a prospective adult research cohort with inflammatory bowel disease (SPARC IBD) LE Raffals, S Saha, M Bewtra, C Norris, A Dobes, C Heller, S O’Charoen, ... Inflammatory bowel diseases 28 (2), 192-199, 2022 | 21 | 2022 |
| Vaccination in patients with inflammatory bowel disease F Caldera, MS Hayney, FA Farraye Official journal of the American College of Gastroenterology| ACG 115 (9 …, 2020 | 21 | 2020 |
| Lower sustained diphtheria and pertussis antibody concentrations in inflammatory bowel disease patients F Caldera, S Saha, A Wald, CA Garmoe, S McCrone, B Megna, D Ley, ... Digestive Diseases and Sciences 63, 1532-1540, 2018 | 21 | 2018 |
| Overlap of juvenile polyposis syndrome and cowden syndrome due to de novo chromosome 10 deletion involving BMPR1A and PTEN: Implications for treatment … A Alimi, LA Weeth‐Feinstein, A Stettner, F Caldera, JM Weiss American journal of medical genetics Part A 167 (6), 1305-1308, 2015 | 21 | 2015 |
| Hepatitis-B vaccine response in inflammatory bowel disease patients: a systematic review and meta-analysis GS Kochhar, BP Mohan, SR Khan, S Chandan, LL Kassab, S Ponnada, ... Inflammatory bowel diseases 27 (10), 1610-1619, 2021 | 20 | 2021 |
| High but inequitable COVID-19 vaccine uptake among patients with inflammatory bowel disease TL Schell, LJ Richard, K Tippins, RK Russ, MS Hayney, F Caldera Clinical Gastroenterology and Hepatology 20 (7), 1606-1608. e2, 2022 | 18 | 2022 |
| Using number needed to harm to put the risk of herpes zoster from tofacitinib in perspective F Caldera, MS Hayney, RK Cross Inflammatory bowel diseases 25 (6), 955-957, 2019 | 18 | 2019 |
| Safety of immunizations for the adult patient with inflammatory bowel disease—a systematic review and meta-analysis A Desalermos, M Pimienta, M Kalligeros, F Shehadeh, L Diamantopoulos, ... Inflammatory Bowel Diseases 28 (9), 1430-1442, 2022 | 17 | 2022 |
| Higher cell-mediated immune responses in patients with inflammatory bowel disease on anti-TNF therapy after COVID-19 vaccination F Caldera, FA Farraye, BM Necela, D Cogen, S Saha, A Wald, ND Daoud, ... Inflammatory bowel diseases 29 (8), 1202-1209, 2023 | 16 | 2023 |
| Effectiveness of recombinant zoster vaccine (RZV) in patients with inflammatory bowel disease GS Kochhar, A Desai, F Caldera, S El Hachem, E Aoun, D Sandhu, ... Vaccine 39 (30), 4199-4202, 2021 | 15 | 2021 |
| The burden of vaccine-preventable diseases in patients with inflammatory bowel disease PT Kröner, MF Picco, JR Cangemi, MS Hayney, FA Farraye, F Caldera Journal of Clinical Gastroenterology 56 (9), 798-804, 2022 | 14 | 2022 |
